stars 1 stars 2 stars 3

Phage Technologies has created and developed a platform from discovery to industrial production of new antibacterial compounds based on bacteriophages. These compounds are microscopic bacterial viruses able to infect specifically targeted bacteria. This allows to selectively eliminate pathogenic bacterias that decrease productivity in the livestock industry. Phage Technologies products can be considered as substitutes to traditional antibiotics. Milkeeper S is its first product and is sold as a milk additive for calves that prevents Escherichia coli and Salmonella infections during rearing. These bacteria can produce 15% of mortality and 85% of them present antibiotic resistance. Milkeeper S can control those infections reducing mortality to 2%, increasing the animal weight by 10% and reducing 70% of the antibiotic consumption, without inducing resistance, during rearing.

Phage Technologies S.A Questions

The Phage Technologies S.A annual revenue was $1 million in 2026.

Flavia Callafange is the Global Sales Director of Phage Technologies S.A.

2 people are employed at Phage Technologies S.A.

The NAICS codes for Phage Technologies S.A are [541, 54171, 541713, 54, 5417].

The SIC codes for Phage Technologies S.A are [87, 873].

Top Phage Technologies S.A Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users